| Literature DB >> 30718486 |
Gang Wang1, Xiaodong Xin2, Zehua Wang2, Gang Lu2, Yudao Ma2, Lei Liu3,4.
Abstract
Catalytic enantioselective C-C bond forming process through cross-dehydrogenative coupling represents a promising synthetic strategy, but it remains a long-standing challenge in chemistry. Here, we report a formal catalytic enantioselective cross-dehydrogenative coupling of saturated ethers with diverse carboxylic acid derivatives involving an initial oxidative acetal formation, followed by nickel(II)-catalyzed asymmetric alkylation. The one-pot, general, and modular method exhibits wide compatibility of a broad range of saturated ethers not only including prevalent tetrahydrofuran and tetrahydropyran, but also including medium- and large-sized cyclic moieties and acyclic ones with excellent enantioselectivity and functional group tolerance. The application in the rapid preparation of biologically active molecules that are difficult to access with existing methods is also demonstrated.Entities:
Year: 2019 PMID: 30718486 PMCID: PMC6362111 DOI: 10.1038/s41467-019-08473-x
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Reaction condition optimizationa
|
| |||||
|---|---|---|---|---|---|
| Entry | L/Lewis acid | Additive | Yield (%)b | d.r.c | ee (%)d |
| 1 | TBAI | <5 | n.d. | n.d. | |
| 2 | Fe(acac)3 | 7 | 50:50 | 6/9 | |
| 3 | Cu(acac)2 | 9 | 50:50 | 10/12 | |
| 4 | Cu(OAc)2 | 11 | 50:50 | 13/14 | |
| 5 | CuOAc | 14 | 50:50 | 17/16 | |
| 6e | CuOAc | 19 | 50:50 | 23/21 | |
| 7e,f | CuOAc | 27 | 51:49 | 28/26 | |
| 8e,f | CuOAc | 25 | 55:45 | 34/35 | |
| 9e,f | CuOAc | <5 | n.d. | n.d. | |
| 10e,f | CuOAc | 21 | 54:46 | 26/23 | |
| 11e,f | CuOAc | <5 | n.d. | n.d. | |
| 12e,f | CuOAc | 40 | 53:47 | 49/46 | |
| 13e,f | CuOAc | 38 | 55:45 | 60/61 | |
| 14e,f | CuOAc | 50 | 62:38 | 79/78 | |
| 15e,f | CuOAc | <5 | n.d. | n.d. | |
| 16e,f | CuOAc | 54 | 64:36 | 82/81 | |
| 17e,f | CuOAc | 55 | 63:37 | 80/80 | |
| 18e,f,g | CuOAc | 61 | 64:36 | 82/81 | |
| 19e,f,g,h | CuOAc | 86 | 66:34 | 90/88 | |
| 20e,f,g,h,i | CuOAc | 80 | 68:32 | 96/95 | |
| 21e,f,g,h,i,j | CuOAc | 81 | 67:33 | 98/98 | |
| 22e,f,g,h,i,j,k | CuOAc | 12 | 66:34 | 96/97 | |
n.d., not determined
aReaction condition: hexanoic acid (0.5 mmol, 2.5 equiv), additive (0.02 mmol, 10 mol%), and tBuOOH in decane (0.5 mmol, 2.5 equiv) in THF (1 mL) at 80 °C for 2 h, followed by addition of 2a (0.2 mmol, 1.0 equiv), L (0.024 mmol, 12 mol%), Lewis acid (0.02 mmol, 10 mol%), 2,4,6-collidine (0.6 mmol, 3.0 equiv), and BF3·OEt2 (0.6 mmol, 3.0 equiv) in CH2Cl2 (0.4 mL) at rt for 2 h, unless otherwise noted
bIsolated yield of the two diastereomers
cDetermined by 1H NMR spectroscopy
dDetermined by chiral HPLC analysis
eCuOAc (0.005 mmol, 2.5 mol%) used
fAcetyloxazolidinethione 2aa used
gPre-prepared L6·Ni(OTf)2 used
hBF3·OEt2 (0.8 mmol, 4.0 equiv) used
iTHF/CH2Cl2 (3:1, v/v) as solvent for nucleophilic addition step
jPhCOOH instead of hexanoic acid as protic additive
kAsymmetric nucleophilic addition reaction performed at 0 °C
Fig. 1The scope of α-aryl acetic acid derivatives. Conditions: PhCOOH (0.5 mmol, 2.5 equiv), CuOAc (2.5 mol%), tBuOOH in decane (2.5 equiv) in THF (1.0 mL) at 80 °C for 2 h, followed by 2 (1.0 equiv), L6·Ni(OTf)2 (10 mol%), 2,4,6-collidine (3.0 equiv) and BF3·OEt2 (4.0 equiv) in THF/CH2Cl2 (0.3 mL/0.1 mL) at rt for 2 h
Fig. 2The scope of α-alkenyl acetic acid derivatives. Conditions: PhCOOH (0.5 mmol, 2.5 equiv), CuOAc (2.5 mol%), tBuOOH in decane (2.5 equiv) in THF (1.0 mL) at 80 °C for 2 h, followed by 2 (1.0 equiv), L5·Ni(OTf)2 (10 mol%), 2,4,6-collidine (3.0 equiv), and BF3·OEt2 (4.0 equiv) in CH3CO2CH3/CH2Cl2 (0.3 mL/0.1 mL) at rt for 2 h
Fig. 3The scope of cyclic saturated ethers. Conditions: PhCOOH (0.5 mmol, 2.5 equiv), CuOAc (2.5 mol%), tBuOOH in decane (3.0 equiv) in ether (1.0 mL) at 80 °C for 6–12 h, followed by 2 (1.0 equiv), L5·Ni(OTf)2 or L6·Ni(OTf)2 (10 mol%), 2,4,6-collidine (3.0 equiv), and BF3·OEt2 (4.0 equiv) in CH2Cl2 (0.4 mL) at rt for 2 h
Fig. 4The scope of acyclic saturated ethers. Conditions: PhCOOH (0.5 mmol, 2.5 equiv), CuOAc (2.5 mol%), tBuOOH in decane (3.0 equiv) in ether (1.0 mL) at 80 °C for 6–12 h, followed by 2 (1.0 equiv), L6·Ni(OTf)2 (10 mol%), 2,4,6-collidine (3.0 equiv), and BF3·OEt2 (4.0 equiv) in CH2Cl2 (0.4 mL) at rt for 2 h
Fig. 5Synthetic utilities. a Transformations of oxa- and thiazolidinethiones to other synthetically valuable functional groups. b Rapid synthesis of two dopamine transporter inhibitors. c Removal of the oxa- and thiazolidinethione moieties
Fig. 6Mechanistic studies. a Reaction intermediate identification. b Asymmetric coupling of 18 with 2aa. c Asymmetric coupling of 18 with 2aa in the absence of CuOAc. d Identification of the real metal catalyst for the asymmetric coupling
Fig. 7A proposed catalytic cycle. The possible reaction pathway based on our studies and previous literature
Fig. 8Stereochemical induction model with chiral Ni-bound Z-enolate. The geometry was optimized at the B3LYP/LANL2DZ–6–31G(d) level